In the present study, we observed elevated FGFR2, FRS2, and AKT activation after intranasal FGF10 delivery and AAV9‐mediated FGF10 gene delivery in 3xTg‐AD mice and APPswe‐transfected HT22 cells. This evidence concerns the gene FGFR2 and Alzheimer disease.